Shuttle Pharmaceuticals Holdings, Inc.SHPH

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NASDAQ · United States · shuttlepharma.com

Shuttle Pharmaceuticals Holdings, Inc. owns an AI-driven pharmaceutical software platform, Molecule.ai, for molecular discovery and early-stage drug development. Its wholly-owned subsidiary United Dogecoin is a start-up digital infrastructure company developing large-scale computing capacity for blockchain networks, artificial intelligence and high-performance computing workloads.

Key ratios

ROA

-81.7%TTM

2025 -114.7%2024 -113.7%2023 -50.4%

ROE

-791.0%2025

2024 -383.8%2023 -112.4%

Recent news

Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter 2026-08-28 · Newsfile

Track SHPH in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer